← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

NVX logoNovonix Limited(NVX)Earnings, Financials & Key Ratios

NVX•NASDAQ
$0.73
$157M mkt cap·Price updated May 6, 2026
SectorIndustrialsIndustryElectrical EquipmentSub-IndustryBattery Cells and Materials
AboutNovonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. It operates through three segments: Graphite Exploration and Mining, Battery Technology, and Battery Materials. The Graphite Exploration and Mining segment explores for graphite in Australia. The Battery Technology segment develops battery cell testing equipment and batteries, and consulting services. The Battery Materials segment develops and manufactures battery anode materials. The company is also involved in the investment and battery testing activities. Novonix Limited has strategic alliance with Harper International Corporation to develop specialized furnace technology that would enhance Novonix's synthetic graphite manufacturing process; and partnership with Emera Technologies to develop and manufacture energy storage systems for community microgrids. The company was formerly known as Graphitecorp Limited and changed its name to Novonix Limited in July 2017. Novonix Limited was incorporated in 2012 and is headquartered in Brisbane, Australia.Show more
  • Revenue$6M-51.8%
  • EBITDA-$47M-15.3%
  • Net Income-$75M-61.8%
  • EPS (Diluted)-0.60-7.1%
  • Gross Margin69.76%-9.1%
  • EBITDA Margin-801.94%-138.9%
  • Operating Margin-879.99%-134.8%
  • Net Margin-1278.04%-235.3%
  • ROE-46.54%-68.7%
  • ROIC-25.58%+7.9%
  • Debt/Equity0.51+38.0%
  • Interest Coverage-14.48+8.8%
Technical→

NVX Key Insights

Novonix Limited (NVX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Trading at only 0.7x book value

✗Weaknesses

  • ✗Weak Piotroski F-Score: 1/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 9 (bottom 9%)
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

NVX Price & Volume

Novonix Limited (NVX) stock price & volume — 10-year historical chart

Loading chart...

NVX Growth Metrics

Novonix Limited (NVX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years6.6%
3 Years-1.37%
TTM24.03%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-55.49%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-60.15%

Return on Capital

10 Years-31.17%
5 Years-18.37%
3 Years-20.23%
Last Year-23.67%

NVX Recent Earnings

Novonix Limited (NVX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/12 qtrs (83%)●Beat Revenue 1/12 qtrs (17%)
Q1 2026Latest
Feb 26, 2026
EPS
$0.44
Est $0.11
-287.5%
Revenue
$3M
Est $4M
-21.0%
Q3 2025
Aug 21, 2025
EPS
$0.13
Est $0.26
+49.7%
Revenue
$3M
Est $3M
-12.3%
Q1 2025
Feb 28, 2025
EPS
$0.06
Est $0.12
+54.4%
Revenue
$2M
Est $4M
-47.6%
Q4 2024
Oct 29, 2024
EPS
$0.04
Est $0.18
+77.8%
Revenue
$2M
Est $3M
-36.0%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 26, 2026
$0.44vs $0.11-287.5%
$3Mvs $4M-21.0%
Q3 2025Aug 21, 2025
$0.13vs $0.26+49.7%
$3Mvs $3M-12.3%
Q1 2025Feb 28, 2025
$0.06vs $0.12+54.4%
$2Mvs $4M-47.6%
Q4 2024Oct 29, 2024
$0.04vs $0.18+77.8%
$2Mvs $3M-36.0%
Based on last 12 quarters of dataView full earnings history →

NVX Peer Comparison

Novonix Limited (NVX) competitors in Battery Cells and Materials — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
CBAT logoCBATCBAK Energy Technology, Inc.Direct Competitor70.85M0.796.08-13.61%-4.03%-5.5%0.25
MVST logoMVSTMicrovast Holdings, Inc.Direct Competitor633.36M1.96-21.7812.56%-6.83%-7.4%0.45
GPRE logoGPREGreen Plains Inc.Product Competitor1.19B16.97-9.43-14.93%-5.8%-15.71%0.66
KORE logoKOREKORE Group Holdings, Inc.Product Competitor155.8M9.16-1.213.43%-24.51%
ENPH logoENPHEnphase Energy, Inc.Product Competitor4.72B35.8027.7510.72%9.64%13.28%1.14
FLUX logoFLUXFlux Power Holdings, Inc.Product Competitor28.38M1.33-3.339.22%-8.36%-67.4%
CLNE logoCLNEClean Energy Fuels Corp.Product Competitor491.3M2.24-2.222.16%-52.22%-39.29%0.18
ALB logoALBAlbemarle CorporationSupply Chain22.7B192.61-33.50-4.37%-5%-2.7%0.34

Compare NVX vs Peers

Novonix Limited (NVX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CBAT

Most directly comparable listed peer for NVX.

Scale Benchmark

vs TSLA

Larger-name benchmark to compare NVX against a more recognizable public peer.

Peer Set

Compare Top 5

vs CBAT, MVST, GPRE, KORE

NVX Income Statement

Novonix Limited (NVX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Dec'22Dec'23Dec'24TTM
Sales/Revenue80.81K2.17M1.82M4.25M5.23M6.1M3.69M12.13M5.85M12.97M
Revenue Growth %290.37%2587.76%-16.34%134.08%22.9%16.72%-39.46%228.54%-51.75%24.03%
Cost of Goods Sold1.41M2.77M3.34M6.7M8.51M1.72M24.32M2.82M1.77M46.09M
COGS % of Revenue1739.69%127.48%183.84%157.47%162.71%28.27%658.56%23.22%30.24%-
Gross Profit
-1.32M▲ 0%
-596.8K▲ 55.0%
-1.52M▼ 155.3%
-2.44M▼ 60.5%
-3.28M▼ 34.1%
4.38M▲ 233.5%
-20.63M▼ 571.4%
9.32M▲ 145.2%
4.08M▼ 56.2%
-33.12M▲ 0%
Gross Margin %-1639.69%-27.48%-83.84%-57.47%-62.71%71.73%-558.56%76.78%69.76%-255.27%
Gross Profit Growth %-6500.89%54.96%-155.25%-60.45%-34.11%233.51%-571.38%145.16%-56.17%-
Operating Expenses4.13M7.84M9.77M13.1M12.7M52.42M18.45M5.24M55.6M62.42M
OpEx % of Revenue5112.66%360.94%537.74%307.94%243.04%859.18%499.66%43.16%949.75%-
Selling, General & Admin4.2M6.98M8.32M13.1M12.7M39.86M15.69M44.78M49.08M56.72M
SG&A % of Revenue5194.09%321.17%457.7%307.94%243.04%653.3%424.89%368.99%838.27%-
Research & Development0002.35M5.71M5.1M2.76M5.75M4.85M10.48M
R&D % of Revenue---55.34%109.16%83.64%74.78%47.39%82.84%-
Other Operating Expenses83.26K91.56K231.05K580.03K14.54K605.04K001.68M1000K
Operating Income
-5.46M▲ 0%
-8.44M▼ 54.6%
-11.29M▼ 33.9%
-15.54M▼ 37.6%
-15.98M▼ 2.8%
-47.47M▼ 197.0%
-39.08M▲ 17.7%
-45.47M▼ 16.3%
-51.52M▼ 13.3%
-95.54M▲ 0%
Operating Margin %-6752.35%-388.42%-621.57%-365.41%-305.75%-778.11%-1058.22%-374.73%-879.99%-736.42%
Operating Income Growth %-394.02%-54.61%-33.88%-37.61%-2.83%-197.04%17.67%-16.34%-13.3%-
EBITDA-5.45M-8.28M-10.8M-14.16M-14.28M-43.26M-35.57M-40.73M-46.95M-86.17M
EBITDA Margin %-6745.76%-381.32%-594.34%-332.96%-273.27%-709.03%-963.04%-335.67%-801.94%-664.17%
EBITDA Growth %-394.84%-51.93%-30.4%-31.14%-0.87%-202.84%17.78%-14.51%-15.26%-24.66%
D&A (Non-Cash Add-back)5.32K154.25K494.95K1.38M1.7M4.21M3.52M4.74M4.57M9.37M
EBIT-4.26M-7.09M-17.47M-11.07M-13.31M-50.39M-53.84M-43.6M-71.18M-114.52M
Net Interest Income-561.09K-481.86K-1.09M-3.57M-144.96K-1.5M-1.85M-1.25M-2.19M-5.96M
Interest Income4.37K4.95K3.17K48526.16K8.31K26.54K1.61M1.37M1.89M
Interest Expense565.46K486.81K1.1M3.57M171.12K1.47M1.29M2.87M3.56M7.38M
Other Income/Expense-717.32K-431.17K-14.46M-6.63M-2.09M-3.82M1M-976.64K-23.21M-18.28M
Pretax Income
-6.17M▲ 0%
-8.87M▼ 43.6%
-25.75M▼ 190.4%
-20.03M▲ 22.2%
-18.08M▲ 9.7%
-51.86M▼ 186.9%
-38.08M▲ 26.6%
-46.45M▼ 22.0%
-74.72M▼ 60.9%
-113.82M▲ 0%
Pretax Margin %-7640.04%-408.27%-1417.33%-470.88%-345.8%-850.01%-1031.13%-382.78%-1276.38%-877.3%
Income Tax-243.07K13.4K-383.65K0001-199.95K97.69K-111.32K
Effective Tax Rate %3.94%-0.15%1.49%0%0%0%-0%0.43%-0.13%0.1%
Net Income
-6.14M▲ 0%
-10.32M▼ 68.3%
-26.12M▼ 153.0%
-20.03M▲ 23.3%
-18.08M▲ 9.7%
-51.86M▼ 186.9%
-38.08M▲ 26.6%
-46.25M▼ 21.4%
-74.82M▼ 61.8%
-113.71M▲ 0%
Net Margin %-7592.94%-475.32%-1437.6%-470.88%-345.8%-850.01%-1031.13%-381.13%-1278.04%-876.47%
Net Income Growth %-393.3%-68.25%-153.04%23.33%9.75%-186.9%26.56%-21.44%-61.78%-55.49%
Net Income (Continuing)-5.93M-10.32M-25.37M-20.03M-18.08M-51.86M-55.73M-46.25M-74.82M-122.59M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-0.22▲ 0%
-0.26▼ 18.2%
-0.22▲ 15.4%
-0.17▲ 22.7%
-0.16▲ 5.9%
-0.44▼ 175.0%
-0.30▲ 31.8%
-0.56▼ 86.7%
-0.60▼ 7.1%
-0.72▲ 0%
EPS Growth %-274.15%-18.18%15.38%22.73%5.88%-175%31.82%-86.67%-7.14%-60.15%
EPS (Basic)-0.22-0.26-0.22-0.17-0.16-0.44-0.30-0.56-0.60-
Diluted Shares Outstanding116.11M116.11M116.11M116.11M116.11M116.11M121.65M121.87M124.22M157.01M
Basic Shares Outstanding116.11M116.11M116.11M116.11M116.11M116.11M121.65M121.87M124.22M157.01M
Dividend Payout Ratio----------

NVX Balance Sheet

Novonix Limited (NVX) balance sheet — assets, liabilities & shareholders' equity

Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Dec'22Dec'23Dec'24TTM
Total Current Assets3.11M1.85M7.85M41.4M144.03M162.22M79.38M89.15M57.3M52.73M
Cash & Short-Term Investments2.42M396.22K6.05M38.81M136.66M142.74M73.93M78.63M42.56M26.95M
Cash Only2.42M396.22K6.05M38.81M136.66M142.74M73.93M115.49M42.56M26.95M
Short-Term Investments0000000702.87K00
Accounts Receivable289.99K595.91K478.4K1.23M2.04M2.45M1.95M3.56M8.16M18.89M
Days Sales Outstanding1.31K100.1596.1105.36142.65146.72192.29107.21508.63225.04
Inventory318.69K646.14K1.12M1.37M2.78M1.87M2.16M2M1.38M1.76M
Days Inventory Outstanding82.7585.18122.0574.5119.32396.2332.47259.22285.312.95
Other Current Assets153.12K250.99K126.17K01.63M10.09M03.01M3.5M2.17M
Total Non-Current Assets32.39M35.2M27.07M33.85M58.83M140.76M110.22M174.19M168.8M186.31M
Property, Plant & Equipment150.38K2.44M5.98M12.47M38.99M111.56M89M144.28M155.67M173.02M
Fixed Asset Turnover0.54x0.89x0.30x0.34x0.13x0.05x0.04x0.08x0.04x0.09x
Goodwill3.4M4.55M17.04M17.41M15.95M11.98M8.18M11.98M11.98M11.97M
Intangible Assets408.25K5.03M18.23M18.37M16.58M389.75K8.32M10.41K00
Long-Term Investments13.09M11.64M00016.67M11.27M16.63M027.68M
Other Non-Current Assets12.68M8.71M-14.19M-14.4M-12.69M168.71K1.63M1.32M1.16M4.3M
Total Assets
35.5M▲ 0%
37.05M▲ 4.4%
34.92M▼ 5.8%
75.26M▲ 115.5%
202.86M▲ 169.6%
302.98M▲ 49.4%
189.59M▼ 37.4%
263.34M▲ 38.9%
226.1M▼ 14.1%
239.04M▲ 0%
Asset Turnover0.00x0.06x0.05x0.06x0.03x0.02x0.02x0.05x0.03x0.06x
Asset Growth %1113.75%4.38%-5.76%115.51%169.55%49.36%-37.42%38.9%-14.14%49.02%
Total Current Liabilities13.13M973.03K6.13M4.01M5.35M7.89M5.79M7.84M46.24M56.57M
Accounts Payable257.82K331.79K1.31M2.47M1.37M2.65M2.81M1.34M998.26K18.48M
Days Payables Outstanding66.9443.74142.89134.6758.76561.2742.13173.91205.854.57
Short-Term Debt9.22M86.89K4.15M189.08K124.77K119.97K78.01K1.97M30.64M33.16M
Deferred Revenue (Current)00098.78K310.1K2.71K49.19K418K126.06K3.79M
Other Current Liabilities3.66M554.35K677.5K1.25M1.65M896.08K750.98K-1.07M6.76M1.43M
Current Ratio0.24x1.90x1.28x10.33x26.90x20.56x13.72x11.37x1.24x1.24x
Quick Ratio0.21x1.24x1.10x9.99x26.38x20.32x13.35x11.12x1.21x1.21x
Cash Conversion Cycle1.33K141.5975.2645.19203.21-18.32182.62192.52588.13183.42
Total Non-Current Liabilities3.95M6.9M18.25M10.94M19.33M43.96M32.41M105M42.26M43.17M
Long-Term Debt2.43M1.21M18.25M8.16M12.21M35.95M27.06M99.28M32.78M36.97M
Capital Lease Obligations0002.78M7.12M5.01M4.83M4.48M6.49M23.92M
Deferred Tax Liabilities1.52M2.83M00001.25M00-4K
Other Non-Current Liabilities05.69M0005.94K01.24M03.05M
Total Liabilities17.08M7.87M24.38M14.94M24.68M51.85M38.2M83.74M88.51M99.73M
Total Debt11.64M4.16M22.39M11.35M20.01M41.41M31.34M68.22M70.42M76.33M
Net Debt9.23M3.76M16.34M-27.46M-116.65M-101.32M-42.58M-10.49M27.86M49.38M
Debt / Equity0.63x0.14x2.12x0.19x0.11x0.16x0.21x0.37x0.51x0.51x
Debt / EBITDA----------0.89x
Net Debt / EBITDA----------0.57x
Interest Coverage-9.65x-17.33x-10.30x-4.35x-93.40x-32.33x-30.31x-15.87x-14.48x-15.52x
Total Equity
18.41M▲ 0%
29.18M▲ 58.5%
10.54M▼ 63.9%
60.31M▲ 472.0%
178.18M▲ 195.4%
251.13M▲ 40.9%
151.39M▼ 39.7%
183.94M▲ 21.5%
137.59M▼ 25.2%
139.3M▲ 0%
Equity Growth %578.8%58.48%-63.87%472.02%195.42%40.95%-39.72%21.49%-25.2%-1.44%
Book Value per Share0.160.250.090.521.532.161.241.511.110.89
Total Shareholders' Equity18.41M29.18M10.54M60.31M178.18M251.13M151.39M183.94M137.59M139.3M
Common Stock22.21M38.16M38.16M99.85M233.2M338.01M231.06M338.43M367.54M392.54M
Retained Earnings-7.38M-17.71M-43.83M-63.86M-81.93M-110.74M-94.72M-184.85M-259.67M-279.81M
Treasury Stock0000000000
Accumulated OCI3.59M8.73M16.21M24.32M26.91M23.86M15.05M30.36M29.72M26.57M
Minority Interest0000000000

NVX Cash Flow Statement

Novonix Limited (NVX) cash flow — operating, investing & free cash flow history

Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Dec'22Dec'23Dec'24TTM
Cash from Operations-749.64K-2.87M-2.81M-3.75M-6.09M-29.23M-12.89M-36.23M-40.42M-40.42M
Operating CF Margin %-927.69%-132.14%-154.55%-88.15%-116.45%-479.08%-349.09%-298.56%-690.38%-
Operating CF Growth %-60.43%-282.84%2.15%-33.51%-62.36%-380.18%55.89%-180.99%-11.56%-60.72%
Net Income-4.72M-7.64M-18.34M-13.43M-13.45M-51.86M-38.08M-46.25M-74.82M-113.71M
Depreciation & Amortization7.14K114.17K7.84M1.18M1.26M4.21M3.52M4.74M4.57M6.86M
Stock-Based Compensation2.75M005.07M4.47M14.68M03.83M5.52M0
Deferred Taxes0074.31K-4.41M-2.85M2.79M-4.91M000
Other Non-Cash Items1.21M-40.2K3.01M8.5M6.09M-172.95K27.03M961.98K21.26M25.4M
Working Capital Changes1.78M-1.35M-74.31K-654.85K-1.62M1.12M1.55M491.56K3.05M0
Change in Receivables000-654.85K-1.62M0158.79K-582.43K1.6M0
Change in Inventory000201.3K866.51K166.18K-945.58K1.23M455.64K0
Change in Payables188.4K-124.52K288.42K387.2K-145.62K-90.69K916.22K-1.4M1.42M0
Cash from Investing-11.16M-3.96M-5.16M-3.69M-19.68M-106.8M-16.1M-12.04M-18.17M-46.06M
Capital Expenditures-1.11M-2.07M-1.52M-3.68M-19.58M-83.79M-16.75M-19.69M-29.91M-65.79M
CapEx % of Revenue1373.56%95.31%83.39%86.45%374.52%1373.35%453.61%162.25%510.84%-
Acquisitions-2.33M0-3.64M0000000
Investments----------
Other Investing375.98K-10.89K-9.24K-10.97K-100K-10.24M651.24K7.65M11.73M19.73M
Cash from Financing12.48M5.34M11.84M30.48M103.77M180.69M-531.57K44.16M25.21M47.92M
Debt Issued (Net)12.29M1.32M11.81M0032.36M-483.62K29.33M-1.73M-3.04M
Equity Issued (Net)230.53K1000K0001000K4.04K338.33K1000K2.34M
Dividends Paid0000000000
Share Repurchases-44.43K-166.83K0-1.31M-7.91M00000
Other Financing-32.03K-82.57K030.48M103.77M-2.64M-203.82K14.49M-1.88M-1.83M
Net Change in Cash
615.29K▲ 0%
-1.59M▼ 357.7%
3.98M▲ 351.0%
22.44M▲ 463.8%
75.91M▲ 238.3%
40.14M▼ 47.1%
-19.47M▼ 148.5%
-20.33M▼ 4.4%
-36.16M▼ 77.9%
-45.06M▲ 0%
Free Cash Flow
-1.86M▲ 0%
-4.94M▼ 165.7%
-4.32M▲ 12.5%
-7.43M▼ 71.8%
-25.66M▼ 245.6%
-113.02M▼ 340.4%
-29.65M▲ 73.8%
-55.42M▼ 86.9%
-70.32M▼ 26.9%
-119.71M▲ 0%
FCF Margin %-2301.25%-227.45%-237.94%-174.59%-490.97%-1852.43%-802.7%-456.75%-1201.21%-922.67%
FCF Growth %-23.24%-165.65%12.48%-71.77%-245.6%-340.37%73.77%-86.95%-26.88%-165.1%
FCF per Share-0.02-0.04-0.04-0.06-0.22-0.97-0.24-0.45-0.57-0.57
FCF Conversion (FCF/Net Income)0.12x0.28x0.11x0.19x0.34x0.56x0.34x0.78x0.54x1.05x
Interest Paid048.31K00000000
Taxes Paid018.67K00000000

NVX Key Ratios

Novonix Limited (NVX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201620172018201920202021202220232024TTM
Return on Equity (ROE)-58.08%-43.38%-131.51%-56.53%-15.16%-24.16%-18.92%-27.58%-46.54%-81.63%
Return on Invested Capital (ROIC)-28.53%-20.89%-28.32%-39.03%-25.4%-33.7%-22.67%-27.79%-25.58%-25.58%
Gross Margin-1639.69%-27.48%-83.84%-57.47%-62.71%71.73%-558.56%76.78%69.76%-255.27%
Net Margin-7592.94%-475.32%-1437.6%-470.88%-345.8%-850.01%-1031.13%-381.13%-1278.04%-876.47%
Debt / Equity0.63x0.14x2.12x0.19x0.11x0.16x0.21x0.37x0.51x0.51x
Interest Coverage-9.65x-17.33x-10.30x-4.35x-93.40x-32.33x-30.31x-15.87x-14.48x-15.52x
FCF Conversion0.12x0.28x0.11x0.19x0.34x0.56x0.34x0.78x0.54x1.05x
Revenue Growth290.37%2587.76%-16.34%134.08%22.9%16.72%-39.46%228.54%-51.75%24.03%

NVX Frequently Asked Questions

Novonix Limited (NVX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Novonix Limited (NVX) reported $13.0M in revenue for fiscal year 2024.

Novonix Limited (NVX) saw revenue decline by 51.8% over the past year.

Novonix Limited (NVX) reported a net loss of $113.7M for fiscal year 2024.

Dividend & Returns

Novonix Limited (NVX) has a return on equity (ROE) of -46.5%. Negative ROE indicates the company is unprofitable.

Novonix Limited (NVX) had negative free cash flow of $119.7M in fiscal year 2024, likely due to heavy capital investments.

Explore More NVX

Novonix Limited (NVX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.